Towards timely diagnosis of symptomatic breast and cervical cancer in South Africa.
S Afr Med J
South African Medical Association NPC
MetadataShow full item record
Moodley, J., Walter, F., Scott, S., & Mwaka, A. (2018). Towards timely diagnosis of symptomatic breast and cervical cancer in South Africa.. S Afr Med J, 108 (10), 803-804. https://doi.org/10.7196/SAMJ.2018.v108i10.13478
The global cancer burden is projected to increase by 50% by 2030 and, disturbingly, most of the increase will occur in LMICs.[1–4] Unique features of cancer in Africa are the disproportionately high burden of cancers in women (56%), the high proportion of infection-related cancers (30% of all cancers) and the late stage at which cancer is diagnosed (e.g. 46% of breast cancer in South Africa (SA) diagnosed at an advanced stage).[3–7] Cancer stage is a measure of cancer growth and spread, with stage at presentation being an important prognostic factor. Earlier stage at presentation, enabling more opportunities for curative treatment and improved outcomes, is thus an important goal in any comprehensive cancer care policy.
Breast Neoplasms, Delayed Diagnosis, Early Detection of Cancer, Female, Health Priorities, Humans, Neoplasm Staging, Primary Health Care, Referral and Consultation, South Africa, Time Factors, Uterine Cervical Neoplasms
SAMRC- is this the same, probably not
MRC (via University of Cape Town) (MRC-RFA-SHIP 01-2015)
Embargo Lift Date
External DOI: https://doi.org/10.7196/SAMJ.2018.v108i10.13478
This record's URL: https://www.repository.cam.ac.uk/handle/1810/279629
Attribution-NonCommercial 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc/4.0/
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org